CPhl China 2023 Invitation

2023/04/20

Table of Content [Hide]

References

Related News

Beilu Pharmaceutical's Repaglinide Tablets Receive Generic Drug Bioequivalence Assessment
June 6, 2023Recently, Beilu Pharmaceutical received the "Drug Supplement Application Approval Notice" (Notice No.: 2023B02662) for repaglinide tablets issued by the National Medical Products Administrat...view
Beilu's Iopamidol Injection Won the Bid for China's Pharmaceutical Centralized Procurement
July 15, 2022On July 12, 2022, Beilu participated in the seventh batch of national centralized drug procurement organized by the National Organization for Centralized Drug Procurement and Use Joint Procurement Off...view
Beilu Pharmaceutical Plans to Acquire Tianyuan Pharmaceutical, Actively Building "Second Growth Curve"
March 1, 2024Recently, Beilu Pharmaceutical announced that it plans to use its own funds to acquire 80% of the equity of Chengde Tianyuan Pharmaceutical Co., Ltd. After the completion of this acquisition, Tianyuan...view
Anti Anxiety Drugs More Effective Than Blood Pressure Medication for Mood-induced Hypertension
July 5, 2022Young and middle-aged people face more problems in life, work, and emotion. So they are prone to anxiety, which can lead to high blood pressure. Therefore, it is important to control and relieve the a...view
Good News: Beilu Pharmaceutical won the 2020 National Adverse Drug Reactions Monitoring and Evaluation Excellent Unit
April 12, 2021On March 11th, the National Medical Products Administration (NMPA) issued the “Notice Recognizing Excellent Units in the National Adverse Drug Reactions Monitoring and Evaluation 2020”.view
Beilu Pharma's Iopamidol Injection passed the Consistency Evaluation of Generic Drugs!
February 18, 2022Recently, Beilu Pharma received the “Approval Notice for Supplementary Drug Application” for two specifications of Iopamidol Injection issued by the NMPA (Notice No.: 2022B00641, 2022B00642). Follow...view

CPhl China 2023 Invitation

Beilu Pharmaceutical's Repaglinide Tablets Receive Generic Drug Bioequivalence Assessment

Beilu's Iopamidol Injection Won the Bid for China's Pharmaceutical Centralized Procurement

Beilu Pharmaceutical Plans to Acquire Tianyuan Pharmaceutical, Actively Building "Second Growth Curve"

Anti Anxiety Drugs More Effective Than Blood Pressure Medication for Mood-induced Hypertension

Good News: Beilu Pharmaceutical won the 2020 National Adverse Drug Reactions Monitoring and Evaluation Excellent Unit

Beilu Pharma's Iopamidol Injection passed the Consistency Evaluation of Generic Drugs!